SPHK1/S1PR1/PPAR-α axis restores TJs between uroepithelium providing new ideas for IC/BPS treatment
Open Access
- 22 November 2024
- journal article
- research article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 8 (2) , e202402957
Abstract
Interstitial cystitis/bladder pain syndrome (IC/BPS) represents a chronic, aseptic inflammatory bladder condition with an unclear etiology and few therapeutic options. A composite barrier structure composed of the uroepithelium and glycosaminoglycan layer forms on the bladder’s inner surface to block urine and other harmful substances. Dysfunction of this barrier may initiate the pathogenesis of IC/BPS. Sphingosine-1-phosphate (S1P) plays a crucial role in forming tight junctions. Perfusion of S1P into the bladder restored uroepithelial tight junctions in mice with cyclophosphamide-induced acute cystitis and ameliorated symptoms of the lower urinary tract. Mice lacking sphingosine kinase 1 (SHPK1) exhibited more severe bladder injuries and dysfunction. Concurrent in vitro experiments elucidated S1P’s protective effects and its role as a primary messenger through SPHK1 and S1P receptor 1 (S1PR1) knockdown. This study identifies a novel mechanism whereby S1P binding to S1PR1 activates the PPAR-α pathway, thereby enhancing cholesterol transport and restoring tight junctions between uroepithelial cells. These findings elucidate the regulatory role of S1P in the bladder epithelial barrier and highlight a promising therapeutic target for IC/BPS.Keywords
Funding Information
- MOST | National Natural Science Foundation of China (82270817)
- MOST | National Natural Science Foundation of China (82370781)
This publication has 46 references indexed in Scilit:
- HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liverJCI Insight, 2016
- Impaired Na+/K+-ATPase Function in Patients with Interstitial Cystitis/Painful Bladder SyndromeJournal of Korean Medical Science, 2016
- An experimental study on amelioration of dyslipidemia-induced atherosclesis by Clematichinenoside through regulating Peroxisome proliferator-activated receptor-α mediated apolipoprotein A-I, A-II and C-IIIEuropean Journal of Pharmacology, 2015
- Sphingosine 1-phosphate signaling at the blood–brain barrierTrends in Molecular Medicine, 2015
- Altered Detrusor Gap Junction Communications Induce Storage Symptoms in Bladder Inflammation: A Mouse Cyclophosphamide-Induced Model of CystitisPLOS ONE, 2014
- An update on the biology of sphingosine 1-phosphate receptorsJournal of Lipid Research, 2014
- S1P1 inhibits sprouting angiogenesis during vascular developmentDevelopment, 2012
- Edg-1, the G protein–coupled receptor for sphingosine-1-phosphate, is essential for vascular maturationJournal of Clinical Investigation, 2000
- Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogensNature, 1993
- Bladder Surface Glycosaminoglycans: An Epithelial Permeability BarrierJournal of Urology, 1990